India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Alembic Pharmaceuticals Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	16262.65 Cr.	P/BV	3.33	Book Value (`)	248.68
52 Week High/Low ( ` )	1304/725	FV/ML	2/1	P/E(X)	26.41
Book Closure	15/07/2024	EPS (`)	31.33	Div Yield (%)	1.33

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1965.63	1965.63	1965.63	1965.63	1885.16

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	39.31	39.31	39.31	39.31	37.70
Total Share Capital	39.31	39.31	39.31	39.31	37.70

Reserves and Surplus	4778.89	4331.16	5198.23	5088.30	3181.71
Total Reserves and Surplus	4778.89	4331.16	5198.23	5088.30	3181.71
Total Shareholders Funds	4818.20	4370.47	5237.54	5127.61	3219.41
Minority Interest	0.00	0.00	0.00	-60.64	-28.96

NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	199.89	886.99
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	4.21	12.19
Other Long Term Liabilities	62.88	69.23	72.14	71.54	73.30
Long Term Provisions	109.51	106.20	95.82	85.52	74.51
Total Non-Current Liabilities	172.39	175.43	167.96	361.16	1046.99

CURRENT LIABILITIES
Short Term Borrowings	430.45	635.87	629.99	0.02	860.50
Trade Payables	735.64	679.81	706.39	668.77	625.93
Other Current Liabilities	223.65	251.19	316.51	560.07	226.98
Short Term Provisions	65.25	70.06	63.64	51.99	38.19
Total Current Liabilities	1454.99	1636.93	1716.53	1280.85	1751.60

Total Capital And Liabilities	6445.58	6182.83	7122.03	6708.98	5989.04

ASSETS
NON-CURRENT ASSETS
Tangible Assets	2546.71	2398.45	1741.47	1703.74	1524.90
Intangible Assets	0.00	0.00	56.38	85.55	26.94
Capital Work-In-Progress	524.36	601.28	2205.79	1944.28	1574.10
Intangible Assets Under Development	0.00	0.00	98.44	237.39	272.08
Fixed Assets	3071.07	2999.73	4102.08	3970.96	3398.02
Non-Current Investments	93.02	96.33	118.40	49.31	17.62
Deferred Tax Assets [Net]	169.64	123.01	5.88	0.00	0.00
Other Non-Current Assets	33.29	53.74	34.88	110.81	110.66
Total Non-Current Assets	3367.02	3272.81	4261.24	4131.08	3526.30


CURRENT ASSETS
Current Investments	0.00	0.00	0.00	186.97	0.00
Inventories	1643.54	1475.27	1609.70	1486.15	1187.53
Trade Receivables	1024.84	1046.40	807.13	348.58	864.75
Cash And Cash Equivalents	126.57	82.27	69.43	105.84	80.75
OtherCurrentAssets	283.61	306.08	374.53	450.36	329.71
Total Current Assets	3078.56	2910.02	2860.79	2577.90	2462.74

Total Assets	6445.58	6182.83	7122.03	6708.98	5989.04

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	183.13	317.96	228.15	349.23	386.98

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	68.61	71.20	63.69	0.45	0.45

Alembic Pharmaceuticals Ltd.

Ratio Analysis - Consolidated

Market Cap.(`)	16262.65 Cr.	P/BV	3.33	Book Value (`)	248.68
52 Week High/Low ( ` )	1304/725	FV/ML	2/1	P/E(X)	26.41
Book Closure	15/07/2024	EPS (`)	31.33	Div Yield (%)	1.33

You can view the Consolidated Ratio Analysis for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00

PER SHARE RATIOS

Basic EPS (Rs.)	31.33	17.40	26.50	60.81	43.97
Diluted EPS (Rs.)	31.33	17.40	26.50	60.81	43.97
Cash EPS (Rs.)	45.25	32.99	40.83	66.05	50.82
Book Value[Excl.RevalReserv]/Share (Rs.)	245.14	222.36	266.47	257.80	169.25
Book Value[Incl.RevalReserv]/Share (Rs.)	245.14	222.36	266.47	257.80	169.25
Revenue From Operations / Share (Rs.)	316.90	287.59	269.95	274.39	244.34
PBDIT / Share (Rs.)	48.93	36.18	47.04	79.75	65.14
PBIT / Share (Rs.)	35.05	22.17	32.45	70.42	56.80
PBT / Share (Rs.)	32.20	19.61	31.55	69.60	53.04
Net Profit / Share (Rs.)	31.38	18.97	26.23	56.72	42.47
NP After MI And SOA / Share (Rs.)	31.33	17.40	26.50	59.94	43.97

PROFITABILITY RATIOS

PBDIT Margin (%)	15.43	12.58	17.42	29.06	26.66
PBIT Margin (%)	11.06	7.70	12.02	25.66	23.24
PBT Margin (%)	10.15	6.82	11.68	25.36	21.70
Net Profit Margin (%)	9.90	6.59	9.71	20.67	17.38
NP After MI And SOA Margin (%)	9.88	6.05	9.81	21.84	17.99
Return on Networth / Equity (%)	12.78	7.82	9.94	22.97	25.74
Return on Capital Employeed (%)	13.80	9.58	11.79	25.49	25.26
Return On Assets (%)	9.55	5.53	7.31	17.56	13.83
Long Term Debt / Equity (X)	0.00	0.00	0.00	0.03	0.27
Total Debt / Equity (X)	0.08	0.14	0.12	0.03	0.54
Asset Turnover Ratio (%)	0.98	0.77	0.73	0.79	0.77

LIQUIDITY RATIOS

Current Ratio (X)	2.12	1.78	1.67	2.01	1.41
Quick Ratio (X)	0.98	0.87	0.72	0.85	0.72
Inventory Turnover Ratio (X)	0.89	0.86	0.78	0.93	0.95
Dividend Payout Ratio (NP) (%)	25.53	57.47	52.82	0.00	39.32
Dividend Payout Ratio (CP) (%)	17.69	31.83	34.06	0.00	33.05
Earning Retention Ratio (%)	74.47	42.53	47.18	0.00	60.68
Cash Earning Retention Ratio (%)	82.31	68.17	65.94	0.00	66.95

COVERAGE RATIOS

Interest Coverage Ratio (%)	17.11	14.17	52.15	97.85	45.21
Interest Coverage Ratio (Post Tax) (%)	11.98	8.43	30.08	70.59	32.09

VALUATION RATIOS

Enterprise Value (Cr.)	19611.97	10301.50	15131.79	19003.45	11697.08
EV / Net Operating Revenue (X)	3.15	1.82	2.85	3.52	2.54
EV / EBITDA (X)	20.39	14.49	16.37	12.12	9.53
MarketCap / Net Operating Revenue (X)	3.10	1.72	2.75	3.52	2.18
Retention Ratios (%)	74.46	42.52	47.17	0.00	60.67
Price / BV (X)	4.01	2.23	2.78	3.70	3.12
Price / Net Operating Revenue (X)	3.10	1.72	2.75	3.52	2.18
EarningsYield	0.03	0.03	0.03	0.06	0.08

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Alembic Pharmaceuticals Ltd.

Balance Sheet - Consolidated

Alembic Pharmaceuticals Ltd.

Ratio Analysis - Consolidated